Compare BOSC & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BOSC | CCEL |
|---|---|---|
| Founded | 1990 | 1989 |
| Country | Israel | United States |
| Employees | N/A | 76 |
| Industry | Computer Communications Equipment | Managed Health Care |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.4M | 30.9M |
| IPO Year | 2002 | 2022 |
| Metric | BOSC | CCEL |
|---|---|---|
| Price | $4.53 | $3.35 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 1 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | ★ 61.3K | 3.2K |
| Earning Date | 05-28-2026 | 04-14-2026 |
| Dividend Yield | N/A | ★ 4.26% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.01 |
| Revenue | N/A | ★ $25,384,279.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $8.97 | $384.00 |
| Revenue Growth | N/A | ★ 9.76 |
| 52 Week Low | $3.80 | $2.72 |
| 52 Week High | $6.72 | $5.43 |
| Indicator | BOSC | CCEL |
|---|---|---|
| Relative Strength Index (RSI) | 58.03 | 42.84 |
| Support Level | $4.43 | $3.02 |
| Resistance Level | $4.93 | $3.92 |
| Average True Range (ATR) | 0.14 | 0.20 |
| MACD | 0.04 | -0.00 |
| Stochastic Oscillator | 86.49 | 21.51 |
BOS Better Online Solutions Ltd is a provider of comprehensive solutions to enterprises, comprised of services, equipment, and custom-made automatic machines. The company manages its business in three reportable divisions: the Supply Chain Solutions Division, the RFID Division, and the Intelligent Robotics Division. The majority of revenue derives from Supply Chain Solutions, which distributes electro-mechanical components, mainly to customers in the aerospace, defense, and other industries, and is a supply chain service provider for aviation customers that seek a comprehensive solution to their component-supply needs. Its geographic areas are Israel, East Asia, India, America, Europe, and the rest of the world. Geographically company derives the majority of its revenue from Israel.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.